NeuroCatch
- Company typePrivate
- Founded2015
- HeadquartersSurrey, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
NeuroCatch firmographics
Firmographics- Name
- NeuroCatch
- Legal name
- NeuroCatch Inc.
- Website
- https://neurocatch.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
NeuroCatch industry classification
Industry- Product category
- Neurodiagnostic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- General Neurology (HLAKAIAA), Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)
Keywords
Where NeuroCatch is headquartered
LocationHeadquarters
- HQ city
- Surrey
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
NeuroCatch business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- NeuroCatch Platform Device Sales: Sale of portable EEG-based medical device hardware to healthcare providers, clinicians, sports organizations, and military programs for cognitive assessment at point of care.
- Platform Software/Services: Software platform services for cognitive brain function assessment. NeuroCatch Platform provided to healthcare providers for processing and analyzing neurological data.
- Clinical/Professional Services: Clinical integration support and professional services for implementing brain vital signs assessments in clinical and performance settings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Federal Healthcare Pricing |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
NeuroCatch product offering
Product offeringCore offering
NeuroCatch develops and sells the NeuroCatch Platform, a portable EEG-based medical device that delivers objective cognitive brain function assessments in approximately 6 minutes at the point of care. The platform measures three event-related potentials (N100, P300, N400) extracted from EEG signals to quantify auditory sensation, basic attention, and cognitive processing. It is sold to healthcare providers, federal healthcare systems, sports organizations, military programs, and corporate wellness buyers.
Product overview
NeuroCatch offers a single unified medical device product called the NeuroCatch Platform. This flagship platform is a portable EEG-based system that delivers rapid, objective cognitive assessments in approximately 6 minutes at the point of care. The platform measures three specific event-related potentials (ERPs) - N100 for auditory sensation, P300 for basic attention, and N400 for cognitive processing - providing healthcare professionals with quantitative brain vital sign metrics. The NeuroCatch Platform is intended to be used in conjunction with other cognitive assessments and is not a standalone diagnostic tool for a specific brain health condition.
Differentiator
Problem solved
Functional benefit
Products and services
- NeuroCatch Platform A portable, non-invasive EEG-based medical device that provides rapid (approximately 6-minute) objective cognitive assessments using the Brain Vital Signs framework. It measures three event-related potentials (N100 for auditory sensation, P300 for basic attention, N400 for cognitive processing) and is intended to be used in conjunction with other cognitive assessments. Registered with the Australian Register of Therapeutic Goods (ARTG 439393) and designated Rx only in the US.
Quantifiable outcome
- Cognitive assessment completed in approximately 6 minutes at point of care
- +2 more outcomes
Companies that use NeuroCatch
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
NeuroCatch technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
NeuroCatch partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and supporting.
- Phoenix Bioscience CorecoreU.S. headquarters location at Phoenix Bioscience Core, a 30-acre medical and bioscience campus with Arizona's major universities, hospital systems, and research facilities. Supported by Greater Phoenix Economic Council (GPEC).
- XLR8 PBC (Phoenix Bioscience Core)supportingSelected for Fall 2025 cohort of XLR8 PBC, a strategic launchpad program supporting health tech companies with access to industry leaders, mentorship, and strategic resources. Part of Phoenix's growing bioscience and medtech ecosystem.
- Garibaldi Performance CentercorePartnership with Whistler's new premier human optimization facility to provide cognitive assessment services at Crankworx Whistler 2025. NeuroCatch provided baseline assessments and brain vital signs for elite downhill mountain bike riders including Aaron Gwin, Dakotah Norton, and Frida Ronning.
- Lovell Government ServicescorePartnership with Service-Disabled Veteran-Owned Small Business (SDVOSB) to provide NeuroCatch Platform to major federal healthcare systems including Veterans Health Administration (VHA), Military Health System (MHS), and Indian Health Service (IHS). NeuroCatch Platform is now available on VA Federal Supply Schedule (FSS), GSA Advantage, and DLA Electronic Catalog (ECAT).
- HealthTech Connex Inc.coreRelated entity that developed the NeuroCatch Platform technology. Co-founder Dr. Ryan D'Arcy serves as President & CSO of both entities. HealthTech Connex operates the brain clinic where NeuroCatch technology was developed.
- ASU/Mayo MedTech AcceleratorsupportingNeuroCatch was an alumnus of the 2025 Arizona State University/Mayo Clinic MedTech Accelerator program, which helped advance the company's U.S. expansion and commercialization strategy.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
NeuroCatch competitors and assessment
Company assessmentEmerging players
- Kernel: Kernel builds non-invasive brain-activity measurement hardware and cognitive performance tools. It is an emerging player in portable cognitive/neural monitoring and partially competes for the same premium cognitive performance and research buyers.
- Muse (Interaxon): Muse sells a consumer EEG brain-sensing headband and accompanying meditation/cognitive apps. It is an emerging player in portable EEG with adjacent brain-health branding, but its regulatory pathway and customer base are consumer rather than clinical.
- Emotiv: Emotiv builds consumer and research EEG headsets with associated cognitive and ERP analytics. It is an emerging player in portable EEG with overlapping neuroscience underpinnings, but skews toward consumer/wellness rather than clinical federal buyers.
- Cumulus Neuroscience: Cumulus Neuroscience offers a cloud-enabled EEG platform that measures multiple cognitive biomarkers for clinical trials and CNS drug development. It overlaps with NeuroCatch on multi-ERP cognitive assessment but is more focused on pharma/biotech customers.
Broad incumbents
- ANT Neuro: ANT Neuro is an established provider of EEG, EMG, and TMS equipment and software for research and clinical neurophysiology. It is a broad incumbent in the same EEG/ERP measurement category but with a much larger product portfolio and enterprise research focus.
- MindMaze: MindMaze develops digital neurotherapeutics and brain-computer interface platforms for neurological recovery and cognitive assessment. It is a broad incumbent working in adjacent neurological assessment and rehabilitation markets.
- Compumedics: Compumedics manufactures EEG, sleep diagnostic, and brain monitoring equipment sold globally to hospitals and researchers. It is a broad incumbent serving similar neurology and sleep customers with a wider hardware portfolio.
Direct peers
- BrainScope: BrainScope develops EEG-based medical devices for objective assessment of traumatic brain injury and concussion in clinical and military settings. It directly competes with NeuroCatch in portable, point-of-care brain function assessment and shares the federal/military buyer profile.
- SyncThink: SyncThink markets eye-tracking and VR-based objective concussion and balance assessment tools used by sports teams and clinicians. It competes with NeuroCatch for the same sports and military concussion/cognitive readiness budgets.
- Advanced Brain Monitoring: Advanced Brain Monitoring produces EEG-based systems for sleep, cognitive performance, and neurological conditions. It is directly comparable to NeuroCatch on portable EEG, ERP-based cognitive assessment, and sports/military use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
NeuroCatch social profiles
Digital presenceNeuroCatch compliance and trust
Trust signalCompliance1 record
NeuroCatch financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroCatch leadership team
Management profileNumber of profiles
Profiles9 records
NeuroCatch funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroCatch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroCatch
What does NeuroCatch do?
NeuroCatch develops and sells the NeuroCatch Platform, a portable EEG-based medical device that delivers objective cognitive brain function assessments in approximately 6 minutes at the point of care. The platform measures three event-related potentials (N100, P300, N400) extracted from EEG signals to quantify auditory sensation, basic attention, and cognitive processing. It is sold to healthcare providers, federal healthcare systems, sports organizations, military programs, and corporate wellness buyers.
Is NeuroCatch a public or private company?
NeuroCatch is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeuroCatch founded?
NeuroCatch was founded in 2015. It employs 11 to 50 people.
Where is NeuroCatch based?
NeuroCatch is headquartered in Surrey, Canada, in the North America region.
How does NeuroCatch make money?
Three revenue lines are on record. NeuroCatch Platform Device Sales are the primary driver. The others are platform Software/Services and clinical/Professional Services.
Who are NeuroCatch's main competitors?
Emerging players on record are Kernel, Muse (Interaxon), Emotiv and Cumulus Neuroscience. Broad incumbents are ANT Neuro, MindMaze and Compumedics. Direct peers are BrainScope, SyncThink and Advanced Brain Monitoring.
Does NeuroCatch have an API?
No public API is recorded for NeuroCatch.
What industry is NeuroCatch in?
NeuroCatch's product category is Neurodiagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAA, General Neurology. Its NAICS code is 334510 and its SIC code is 3845.